Stock screener

RVMD

Conviction 96HealthcareScan · Mon, Aug 10, 2026
RVMD$206.96+0.88%
ResistanceSupportVol 14Insider sell
63 bars
4
5
3
Vol MA14 1.86M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Revolution Medicines, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.revmed.com ↗
Price206.96
Change+0.88%
Gap+0.09%
Rel volume1.79×
Avg volume1.96M
Avg $ vol369.76M
SMA 20188.76
SMA 50176.91
SMA 200119.82
Price vs 50+16.99%
Price vs 200+72.72%
MA stackbullish
50/200 cross—
Supertrendup · 183.08
RSI (14)68
MACD hist1.35
MACD crossbull · 2d
Stoch %K / %D97 / 91
ADX (14)32
+DI / −DI35 / 14
RSI divergence—
MACD divergence—
ATR %+3.63%
ADR %3.99%
52w high206.96
52w low34.70
From 52w high+0.00%
Above 52w low+496.43%
New 52w highYes
SqueezeOff
Bollinger width16.28%
%B1.09
Donchian pos96.75%
Donchian high208.00
Donchian low176.00
AVWAP (52w high)206.23
vs AVWAP high+0.36%
AVWAP (52w low)109.86
vs AVWAP low+88.39%
OBV trendUp
Chaikin MF (20)0.08
Today vs 20d1.79×
Avg vol (14d)1.86M
Avg vol (20d)1.96M
Avg $ vol (20d)369.76M
Market cap44.36B
RS 3m (vs SPY)+38.26%
RS 6m (vs SPY)+99.25%
RS line new highYes
Trend template8/8
Technical rank93.5
1 week+13.43%
1 month+10.74%
3 months+45.94%
6 months+112.29%
1 year+492.16%
YTD+161.91%
P/E-39.21
P/B17.02
P/S—
P/FCF-48.55
EPS-5.95
Div yield—
ROE-43.41%
ROA-26.17%
Debt/Eq—
Current11.38
EV/EBITDA-36.95
Gross margin—
Net margin—
Rev growth—
EPS growth-88.52%
Price target219.90
Target upside6.25%
Analyst ratingBuy
Institutional102.65%
Ent. value43.54B
Revenue0
Net income-644.37M
Gross profit—
Free cash flow-913.73M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out212.6M
Employees883
ListedThu, Feb 13, 2020
Free float152.8M
Float %79.0%
Short interest14M
Days to cover6.8d
Short volume36.4%
Squeeze score55 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$2.34 vs −$1.93
Last surprise-21.2% miss
Setup gradeA+
Conviction96 / 100
Pattern quality—
Tech rank93.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance194.03
Support177.04
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jul 15 – Jul 17
    2 scans
  2. Breaking out now
    Aug 5
    1 scan

Congress activity

Disclosed STOCK Act trades in RVMD

All disclosures →
No recent disclosed trades by Congress in RVMD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RVMD · 2 buys · 8 sells

InsiderSideShares
Anders Jack
Chief Financial Officer · Common Stock · 2026-06-24
Sell4.55K
Anders Jack
Chief Financial Officer · Common Stock · 2026-06-24
Sell9.5K
Anders Jack
Chief Financial Officer · Common Stock · 2026-06-24
Sell5.65K
Anders Jack
Chief Financial Officer · Common Stock · 2026-06-24
Sell300
Anders Jack
Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-24
Exercise20K
Anders Jack
Chief Financial Officer · Common Stock · 2026-06-24
Exercise20K
Anders Jack
Chief Financial Officer · Common Stock · 2026-06-16
Sell2.72K
Cislini Jeff
General Counsel · Common Stock · 2026-06-16
Sell2.16K
Kelsey Stephen Michael
See Remarks · Common Stock · 2026-06-16
Sell4.17K
Mancini Anthony
See Remarks · Common Stock · 2026-06-16
Sell4.62K

SEC filings

EDGAR filings in RVMD · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.